Sickle Cell Disease: Review of Managements in Pregnancy and the Outcome in Ampang Hospital, Selangor
 Management of Sickle Cell Disease in Pregnancy. London: RCOG Green-top Guideline no. 61, July 2011, pp. 2-20.
 Resende Cardoso P. S, Lopes Pessoade Aguiar R. A, Viana M. B, “Clinical complications in pregnant women with sickle cell disease: Prospective study of factors predicting maternal death or near miss,” Revista Brasileira de Hematologia e Hemoterapia, vol.36, no.4, pp. 256-263, 2014.
 Silva-Pinto A. C, Ladeira S. O. D, Brunetta D. M., De Santis G. C, Angulo I. L, Covas DT,” Sickle cell disease and pregnancy: Analysis of 34 patients followed at the Regional Blood Center of RibeirãoPreto, Brazil,”Revista Brasileira de Hematologia e Hemoterapia, vol. 36, no.5, pp. 329-333, 2014.
 Rees DC, Williams TN, Gladwin MT,” Sickle-cell disease,” Lancet, vol.376, no.9757, pp. 2018-2031, December 2010.
 Rogers DT, Molokie R, “Sickle cell disease in pregnancy,”Obstet Gynecol Clin North Am, vol.37, pp. 223-237, 2010.
 Rahimah A, Syahira LO, SitiHida, et al, “Haemoglobin Sickle D Punjab,” Med J Malaysia, vol. 69, pp. 42-43, Feb 2014.
 Lie-Injo LE, Hassan K, Joishy SK, et al., “Sickle cell anemia associated with alpha-thalassemia in Malaysian Indians,” Am J Hematol, vol.22, no.3, pp. 265-274, July 1986.
 Oteng-Ntim E, Meeks D, Seed PT, et al, “Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis,” Blood, vol.125, no.21, pp. 3316-3325, 2015.
 Leborgne-Samuel Y1, Janky E, Venditelli F, “Sickle cell anemia and pregnancy: review of 68 cases in Guadeloupe,” J Gynecol Obstet Biol Reprod (Paris), vol.34, no.8, pp. 830, Dec 2005.
 Gye HW, Kei-ichi K, Eun JB, et al,” Effects of prenatal hydroxyurea: treatment on mouse offspring,” Experimental and Toxicologic Pathology, vol. 56, no. 1–2, pp. 1-7, Oct 2004.
 Diav-Citrin O, Hunnisett L, Sher GD, Koren G,”Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature,” Am J Hematol, vol.60, no.2, pp. 148-150, 1999.
 National Institute for Health and Clinical Excellence. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. NICE clinical guideline 107. London: NICE; 2010
 Villers MS, Jamison MG, De Castro LM, James AH,” Morbidity associated with sickle cell disease in pregnancy,” Am J Obstet Gynaecol,vol.199, no.2 , pp.125, 2008.
 Royal College of Obstetricians and Gynaecologists, Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. London, United Kingdom: Green-top Guideline, No. 379(a) , 2009
 Giovanna Abadia Oliveira Arduini, Letícia Pinto Rodrigues, “Mortality by sickle cell disease in Brazil,” Rev Bras de Hematol Hemoter In Press, 2016.
 Patricia Costa,Alves Pinto et al, “Risk factors for alloimmunozation in patients with sickle cell anemia,” Revista da Associação Médica Brasileira (English Edition), vol. 57, no. 6, pp. 654-659, Nov-Dec 2011.
 Howard RJ, Tuck SM, Pearson TC. Br,” Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome,” J Obstet Gynaecol, vol.102, pp. 947–51, 1995.
 Rajab KE, Issa AA, Mohammed AM, Ajami AA,” Sickle cell disease and pregnancy in Bahrain,” Int J GynaecolObstet, vol. 93, pp.171–175, 2006.
 Al Jama FE, Gasem T, Burshaid S, Rahman J, Al Suleiman SA, Rahman MS,” Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital,” Arch GynecolObstet, vol. 280, pp. 793–797, 2009.
 Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J, “ Guidelines for the management of acute painful crisis in sickle cell disease,” Br J Haematol, vol. 120, pp.744–752, 2003.